- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05786794
Hearing Healthcare Assessment in Rural Communities (HHARC)
Hearing Healthcare Assessment in Rural Communities (HHARC)
Adult hearing loss in is the third most common chronic health condition in the United States. Adults living in rural areas face a higher risk of experiencing hearing loss, and more difficulty receiving testing and treatment than adults in urban settings. The goal of this clinical trial is to develop and test a community-based hearing healthcare patient navigation program in rural Kentucky. The main question this study aims to answer is:
-Can the number of rural adults receiving diagnostic hearing tests be increased?
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Matthew L Bush, M.D.
- Phone Number: 859-218-2167
- Email: matthew.bush@uky.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 years or older)
- Able to speak, understand, and read English.
Exclusion Criteria:
-Under 18
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Rural Clinic Hearing Healthcare Patient Navigation Program
This arm will involve pilot testing of the Patient Navigation Program with adults in rural primary care clinics
|
Patients presenting for routine office visits will be invited to participate in the study and informed consent procedures and study enrollment will be conducted by a research assistant.
Participants will then undergo baseline assessment.
Following baseline measures, participants who screen positive for hearing loss will be contacted by the Patient Navigator (PN) to begin the intervention.
The navigator will contact participants every 2 weeks to focus on addressing key aspects of Hearing Health Care (HHC): education, screening, diagnosis, and treatment.
PNs will assist the patient to undergo a formal audiogram with the 12 months following enrollment.
Each PN session will likely last between 10-30 minutes.
Post-intervention data collection also administered by a trained interviewer, will occur following a diagnostic audiogram with an audiologist or at 12 months following enrollment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants Receiving a Diagnostic Audiogram After Enrollment
Time Frame: From Enrollment to Study Completion at 12 Months
|
Participants will be assisted to reduce barriers in scheduling a diagnostic audiogram within 12 months following enrollment
|
From Enrollment to Study Completion at 12 Months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Matthew L Bush, M.D., University of Kentucky
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 65361
- R33DC019602 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Adult-Onset
-
Radboud University Medical CenterRecruitingHearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Adult-Onset | Hearing Loss, Bilateral Sensorineural, ProgressiveNetherlands
-
PediatrixCompletedHearing Loss | Deafness | Late-Onset Hearing LossUnited States
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Patient Navigation Program for Hearing Health Care
-
Massachusetts General HospitalRecruiting
-
Jonsson Comprehensive Cancer CenterRecruitingBreast Carcinoma | Lung CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Not yet recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBreast Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingContraception | Breastfeeding | Preventive Care / Anticipatory Guidance | Retention in Care | Postpartum HealthUnited States
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingGestational Diabetes | Preventive Care / Anticipatory Guidance | Retention in Care | Postpartum Health | Lifestyle ModificationUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Not yet recruitingStage IV Lung Cancer | Stage III Lung Cancer | Stage II Lung Cancer
-
Wake Forest University Health SciencesThe Duke EndowmentCompletedDepression | Anxiety | Substance Use DisordersUnited States
-
National Cancer Center, KoreaSamsung Medical Center; Seoul National University Hospital; Korea University...UnknownCancer-related FatigueKorea, Republic of